News & Blog
Sort by :
Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022
Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022 Marks the fifth year that Omega has been ranked as
Omega Healthcare Completes Acquisition of ApexonHealth and Vasta Global Boca Raton, FL, April 13, 2022: Omega Healthcare, a leading technology-enabled healthcare management solutions provider, today
Scenario: 2022 diagnosis is a single tumor with renal cell carcinoma (RCC) 8312, papillary renal cell carcinoma 8260, and mucinous tubular and spindle cell carcinoma
#1 Scenario: 2022 pT3 pN0 cM0 Stage IIA Transverse Colon with Extension through the wall into pericolic tissue, 16 nodes (-), no mets on CT.
Tumor Tip of the Week-Multiple Papillary and Multiple Follicular Ca of the Thyroid-Single or Multiple Primary?
Question: If you had multiple papillary tumors such as a micropapillary 8260/3 and a papillary tall cell 8344/3 would we apply rule M6 (single primary)
Scenario: 2022 patient presents to facility and biopsy of liver shows hepatocellular carcinoma scans reveal changes of hepatic cirrhosis, no further workup done, patient expires.
Scenario: 2022 This patient came to our facility with a history of LUTS/BPH. The patient was evaluated during a clinical consultation and had elected to